Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
IRWD — Ironwood Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 6, 2026
REVENUE
$113.0M +6.1%
NET MARGIN
45.4% +7.1 PTS
EPS
$0.31 +24.0%
FREE CASH FLOW
$58.3M +1038.0%

No summary has been written for this call yet.